Buck A - Search Results

1

Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose.

Böni R, Böni RA, Steinert H, Burg G, Buck A, Marincek B, Berthold T, Dummer R, Voellmy D, Ballmer B, et al. Böni R, et al. Among authors: buck a. Br J Dermatol. 1995 Apr;132(4):556-62. doi: 10.1111/j.1365-2133.1995.tb08711.x. Br J Dermatol. 1995. PMID: 7748746

2

Planar coincidence scintigraphy and PET in staging malignant melanoma.

Steinert HC, Voellmy DR, Trachsel C, Bicik I, Buck A, Huch RA, von Schulthess GK. Steinert HC, et al. Among authors: buck a. J Nucl Med. 1998 Nov;39(11):1892-7. J Nucl Med. 1998. PMID: 9829578 Free article.

3

Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose.

Steinert HC, Huch Böni RA, Buck A, Böni R, Berthold T, Marincek B, Burg G, von Schulthess GK. Steinert HC, et al. Among authors: buck a. Radiology. 1995 Jun;195(3):705-9. doi: 10.1148/radiology.195.3.7753998. Radiology. 1995. PMID: 7753998

4

Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations.

Engel H, Steinert H, Buck A, Berthold T, Huch Böni RA, von Schulthess GK. Engel H, et al. Among authors: buck a. J Nucl Med. 1996 Mar;37(3):441-6. J Nucl Med. 1996. PMID: 8772641 Free article.

5

Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography.

Stumpe KD, Urbinelli M, Steinert HC, Glanzmann C, Buck A, von Schulthess GK. Stumpe KD, et al. Among authors: buck a. Eur J Nucl Med. 1998 Jul;25(7):721-8. doi: 10.1007/s002590050275. Eur J Nucl Med. 1998. PMID: 9662594 Clinical Trial.

6

No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2(15)O]-positron emission tomography study.

Gamma A, Buck A, Berthold T, Vollenweider FX. Gamma A, et al. Among authors: buck a. J Clin Psychopharmacol. 2001 Feb;21(1):66-71. doi: 10.1097/00004714-200102000-00012. J Clin Psychopharmacol. 2001. PMID: 11199950

7

PET diagnostic accuracy: improvement with in-line PET-CT system: initial results.

Hany TF, Steinert HC, Goerres GW, Buck A, von Schulthess GK. Hany TF, et al. Among authors: buck a. Radiology. 2002 Nov;225(2):575-81. doi: 10.1148/radiol.2252011568. Radiology. 2002. PMID: 12409597

8

Simplified quantification of FDG metabolism in tumors using the autoradiographic method is less dependent on the acquisition time than SUV.

Burger IA, Burger C, Berthold T, Buck A. Burger IA, et al. Among authors: buck a. Nucl Med Biol. 2011 Aug;38(6):835-41. doi: 10.1016/j.nucmedbio.2011.02.003. Epub 2011 May 6. Nucl Med Biol. 2011. PMID: 21843779

9

Radiation exposure to sonographers from fluorine-18-FDG PET patients.

Griff M, Berthold T, Buck A. Griff M, et al. Among authors: buck a. J Nucl Med Technol. 2000 Sep;28(3):186-7. J Nucl Med Technol. 2000. PMID: 11001504 Free article.

10

[Dopamine-D2 receptor scintigraphy with 123I-iodobenzofuran in malignant melanoma].

Steinert H, Huch-Böni RA, Böni R, Westera G, Buck A. Steinert H, et al. Among authors: buck a. Nuklearmedizin. 1995 Aug;34(4):146-50. Nuklearmedizin. 1995. PMID: 7675644 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,086 results

Search Page

Filters